ALK and neuroblastoma: Crucial oncogenic drivers for the development of NB are MYCN amplification (25–30%), anaplastic lymphoma kinase (ALK) mutations (8–10%), and segmental chromosomal alterations such as extra copies of the 17q chromosome arm and deletions on chromosome arms 1p and 11q [26,30].